However, there is little information about autoantibodies against GRP78 in sera from HCC patients and a correlation between anti-GRP78 autoantibodies and HCC, although high levels of autoantibodies against GRP78 have been detected in the sera from patients with prostate and gastric cancer (31–33). Here, HSPA5 is linked to hepatocellular carcinoma.